Navigation Links
Statement Regarding the Filing of Signatures to Put the Human Embryo Stem Cell Issue on the November Statewide Ballot
Date:7/7/2008

LANSING, Mich., July 7 /PRNewswire-USNewswire/ -- Please attribute the following statement to Dave Doyle, Spokesman for Michigan Citizens Against Unrestricted Science and Experimentation:

"This proposal is deliberately deceptive. Lawyers and politicians intentionally drafted this language to mislead the voters. This proposal will allow unregulated and unrestricted experimentation on human embryos.

This proposal does not ban human cloning in the State Constitution. The proposal states that nothing shall be interpreted to alter or abrogate the current law banning cloning. However, bills have already been introduced in the Michigan legislature to allow for human cloning. This proposal will permit the legalization of cloning.

Voters should not be deceived by this proposal. It will allow for unregulated, unrestricted experimentation on human embryos.

This proposal would allow researchers to ignore any law that would prevent, restrict or regulate the destruction of human embryos.

Human embryonic stem cell research is already legal in Michigan and has been conducted in Michigan for years. It continues today at the University of Michigan Center for Human Embryo Stem Cell Research and other Michigan universities. This proposal will allow for unregulated and unrestricted research."

Paid for by the Michigan Citizens Against Unrestricted Science and Experimentation with regulated funds


'/>"/>
SOURCE Michigan Citizens Against Unrestricted Science andExperimentation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. GO3 Statement Regarding Erroneous Coverage in Star Magazine
2. AAHSA Statement: Therapy Caps Ration Care
3. Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations
4. Test For Life Shares Senator Burr Statement on National HIV Testing Day
5. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
6. Pelosi Statement on Strong Bipartisan Vote in the House for Medicare Improvements Act
7. AHIP Statement on House Passage of H.R. 6331
8. NCPA Statement Supporting H.R. 6331
9. NCPA Statement Endorsing H.R. 6252 and S.3144
10. Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution
11. National Campaign to Prevent Teen and Unplanned Pregnancy Statement on Jamie Lynn Spears
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised ... five on the list of “ 5 US Cities with the Highest Plastic Rates .” ... and Miami. The results were calculated using a survey by RealSelf and ...
(Date:5/2/2016)... ... May 02, 2016 , ... MedaCheck, a leading medication ... outcomes, has announced its partnership with GrandView Health Services. , With decades of ... counter and prescription drug pharmacy services to thousands of residents. Serving Indiana, Ohio, ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- which specializes ... today the outcome of their partnership with Yoloha Yoga- producers of high quality cork ... , SUP yoga has seen a dramatic rise in popularity throughout the last few ...
(Date:5/2/2016)... ... May 02, 2016 , ... One of Hollywood’s best kept ... Dermatology Surgery & Laser Center, in Milford, Penn. “Patients with busy lives want noninvasive ... fat treated and go home or back to work without having to wear recovery ...
(Date:5/2/2016)... Worcester, MA and Shelton, CT (PRWEB) , ... May 02, 2016 ... ... Scott Krug, President and Owner of New England Low Vision and Blindness (NELV&B) ... location will add more flexibility and convenience for people with vision impairments to get ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 , Net Sales of $1.90 ... over the prior year period, and an increase of 1.2% ... Diluted EPS for the first quarter were $0.52 reported, a ... adjusted, an increase of 29.9% over the prior year period ... earnings guidance for 2016 Zimmer Biomet Holdings, Inc. ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: